{"DataElement":{"publicId":"3247288","version":"1","preferredName":"Embolization Therapy Agent Used Name","preferredDefinition":"Text term to represent the name of the arterial embolization or radioembolization agent utilized in the embolization therapy.","longName":"3247278v1.0:3247281v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3247278","version":"1","preferredName":"Embolization Therapy Agent Used","preferredDefinition":"(EM-bo-lih-ZAY-shun) The blocking of an artery by a clot or foreign material. Embolization can be done as treatment to block the flow of blood to a tumor._An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI)_Use; put into service; make work or employ (something) for a particular purpose or for its inherent or natural purpose.","longName":"3225726v1.0:2234899v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3225726","version":"1","preferredName":"Embolization Therapy Agent","preferredDefinition":"(EM-bo-lih-ZAY-shun) The blocking of an artery by a clot or foreign material. Embolization can be done as treatment to block the flow of blood to a tumor.:An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI)","longName":"C15230:C1708","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Embolization Therapy","conceptCode":"C15230","definition":"A procedure in which substances are injected into blood vessels adjacent to a tumor for the purpose of interrupting the blood flow to the cancer cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A041C582-8E17-4C49-E040-BB89AD434307","latestVersionIndicator":"Yes","beginDate":"2011-04-06","endDate":null,"createdBy":"WHITES","dateCreated":"2011-04-06","modifiedBy":"ONEDATA","dateModified":"2011-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2234899","version":"1","preferredName":"Use","preferredDefinition":"Use; put into service; make work or employ (something) for a particular purpose or for its inherent or natural purpose.","longName":"C25340","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Use","conceptCode":"C25340","definition":"A manner, or usual, or accepted practice of using something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9860F29-7486-7421-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-15","modifiedBy":"ONEDATA","dateModified":"2005-06-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A66297D6-4372-070C-E040-BB89AD4346B1","latestVersionIndicator":"Yes","beginDate":"2011-06-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-23","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for TCGA per request by T.Lichtenberg. mc 6/23/11 Released per approval from Tara. mc 6/30/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3247281","version":"1","preferredName":"Embolic Agent Name","preferredDefinition":"A substance used to block an artery, thereby eliminating the blood flow to a specific part of an organ.  An embolic agent may cause permanent or temporary blockage depending on the nature of the material used._The words or language units by which a thing is known.","longName":"3247281v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Plastic Beads","valueDescription":"Plastic Embolic Bead","ValueMeaning":{"publicId":"3248442","version":"1","preferredName":"Plastic Embolic Bead","longName":"3248442","preferredDefinition":"An embolic bead that is made from plastic-like resin or polymer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Plastic Embolic Bead","conceptCode":"C97233","definition":"An embolic bead that is made from a plastic-like resin or polymer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6B67A3F-0689-EF9A-E040-BB89AD433B8D","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6B67A3F-06A2-EF9A-E040-BB89AD433B8D","beginDate":"2011-06-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"ONEDATA","dateModified":"2011-06-27","deletedIndicator":"No"},{"value":"Y-90 Sirsphere","valueDescription":"Yttrium Y 90 Resin Microspheres","ValueMeaning":{"publicId":"3248444","version":"1","preferredName":"Yttrium Y 90 Resin Microspheres","longName":"3248444","preferredDefinition":"An injectable formulation of the radioisotope yttrium Y 90 encapsulated in resin microspheres with potential antineoplastic activity. When injected into arterial vasculature supplying the tumor, yttrium Y 90 resin microspheres occlude tumor blood vessels and selectively deliver a cytotoxic dose of beta emitting yttrium Y 90 to the tumor site, which may result in tumor cell death and tumor regression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yttrium Y 90 Resin Microspheres","conceptCode":"C64539","definition":"An injectable formulation of the radioisotope yttrium Y 90 encapsulated in resin microspheres with potential antineoplastic activity. When injected into arterial vasculature supplying the tumor, yttrium Y 90 resin microspheres occlude tumor blood vessels and selectively deliver a cytotoxic dose of beta emitting yttrium Y 90 to the tumor site, which may result in tumor cell death and tumor regression.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6B67A3F-06AF-EF9A-E040-BB89AD433B8D","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6B67A3F-06C8-EF9A-E040-BB89AD433B8D","beginDate":"2011-06-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"ONEDATA","dateModified":"2011-06-27","deletedIndicator":"No"},{"value":"Other, specify","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A662D07F-CAB6-DC15-E040-BB89AD43367E","beginDate":"2011-06-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-23","modifiedBy":"ONEDATA","dateModified":"2011-06-23","deletedIndicator":"No"},{"value":"Y-90 Therasphere","valueDescription":"Yttrium Y 90 Glass Microspheres","ValueMeaning":{"publicId":"3247284","version":"1","preferredName":"Yttrium Y 90 Glass Microspheres","longName":"3247284","preferredDefinition":"An injectable formulation of yttrium Y 90 consisting of glass microspheres containing the radioisotope yttrium Y 90.  When injected into the tumor vascular bed, yttrium Y 90 glass microspheres occlude tumor blood vessels and deliver a cytotoxic dose of beta radiation to the tumor site, thereby reducing the tumor burden. (NCI04)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yttrium Y 90 Glass Microspheres","conceptCode":"C38679","definition":"An injectable formulation of yttrium Y 90 consisting of glass microspheres containing the radioisotope yttrium Y 90.  When injected into the tumor vascular bed, yttrium Y 90 glass microspheres occlude tumor blood vessels and deliver a cytotoxic dose of beta radiation to the tumor site, thereby reducing the tumor burden. (NCI04)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A662D07F-CAE6-DC15-E040-BB89AD43367E","latestVersionIndicator":"Yes","beginDate":"2011-06-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A662D07F-CAFF-DC15-E040-BB89AD43367E","beginDate":"2011-06-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-23","modifiedBy":"ONEDATA","dateModified":"2011-06-23","deletedIndicator":"No"},{"value":"Gelfoam","valueDescription":"Absorbable Gelatin Sponge","ValueMeaning":{"publicId":"3247286","version":"1","preferredName":"Absorbable Gelatin Sponge","longName":"3247286","preferredDefinition":"A sterile hemostatic agent composed of purified porcine-derived gelatin.  In regional chemotherapy, absorbable gelatin sponge may be used to embolize arteries in the region of a tumor in order to block or retard blood flow; this blockage results in a locally increased concentration of chemotherapeutic agents delivered to the tumor when chemotherapeutic agents are infused into the embolized arterial circulation upstream of the blockage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Absorbable Gelatin Sponge","conceptCode":"C38705","definition":"A sterile hemostatic agent composed of purified porcine-derived gelatin.  In regional chemotherapy, absorbable gelatin sponge may be used to embolize arteries in the region of a tumor in order to block or retard blood flow; this blockage results in a locally increased concentration of chemotherapeutic agents delivered to the tumor when chemotherapeutic agents are infused into the embolized arterial circulation upstream of the blockage.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A662D07F-CB0C-DC15-E040-BB89AD43367E","latestVersionIndicator":"Yes","beginDate":"2011-06-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A662D07F-CB25-DC15-E040-BB89AD43367E","beginDate":"2011-06-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-23","modifiedBy":"ONEDATA","dateModified":"2011-06-23","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3248441","version":"1","preferredName":"Embolic Agent Name","preferredDefinition":"A substance used to block an artery, thereby eliminating the blood flow to a specific part of an organ.  An embolic agent may cause permanent or temporary blockage depending on the nature of the material used.:The words or language units by which a thing is known.","longName":"C97229:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Embolic Agent","conceptCode":"C97229","definition":"A substance used to block an artery, thereby eliminating the blood flow to a specific part of an organ. An embolic agent may cause permanent or temporary blockage depending on the nature of the material used.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6B67A3F-0646-EF9A-E040-BB89AD433B8D","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"ONEDATA","dateModified":"2011-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A662D07F-CAA0-DC15-E040-BB89AD43367E","latestVersionIndicator":"Yes","beginDate":"2011-06-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-23","modifiedBy":"COOPERM","dateModified":"2011-06-30","changeDescription":"Created for TCGA per request by T.Lichtenberg. mc 6/23/11 Released per approval from Tara. mc 6/30/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Embolizing Agent Utilized","type":"Preferred Question Text","description":"Embolizing Agent Utilized","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A662D07F-CB5E-DC15-E040-BB89AD43367E","latestVersionIndicator":"Yes","beginDate":"2011-06-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-23","modifiedBy":"TSESU","dateModified":"2018-07-13","changeDescription":"Created for TCGA per request by T.Lichtenberg. mc 6/23/11 Release per approval from Tara. mc 6/30/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}